145 related articles for article (PubMed ID: 37762688)
1. Silibinin Downregulates Types I and III Collagen Expression via Suppression of the mTOR Signaling Pathway.
Choi S; Ham S; Lee YI; Kim J; Lee WJ; Lee JH
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762688
[TBL] [Abstract][Full Text] [Related]
2. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
3. [In vitro study of effects and mechanism of rapamycin-induced autophagy in keloid fibroblasts].
Gao J; Jiao H; Cao R; Yang Z; Sun X; Zhuang Q; Xiao Z; Yan Z
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 May; 32(3):208-14. PubMed ID: 30044067
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
Cho JW; Il KJ; Lee KS
Int J Mol Med; 2013 May; 31(5):1148-52. PubMed ID: 23503720
[TBL] [Abstract][Full Text] [Related]
5. Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1/2 inhibitor.
Syed F; Sherris D; Paus R; Varmeh S; Singh S; Pandolfi PP; Bayat A
Am J Pathol; 2012 Nov; 181(5):1642-58. PubMed ID: 22982188
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars.
Wong VW; You F; Januszyk M; Gurtner GC; Kuang AA
Ann Plast Surg; 2014; 72(6):711-9. PubMed ID: 24835866
[TBL] [Abstract][Full Text] [Related]
7. CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2.
Tu T; Huang J; Lin M; Gao Z; Wu X; Zhang W; Zhou G; Wang W; Liu W
Int J Mol Med; 2019 Nov; 44(5):1789-1800. PubMed ID: 31545402
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Akt/PI3K/mTOR signaling pathway for complete eradication of keloid disease by sunitinib.
Chen Y; Chen C; Fang J; Su K; Yuan Q; Hou H; Xin H; Sun J; Huang C; Li S; Yuan Z; Luo S
Apoptosis; 2022 Dec; 27(11-12):812-824. PubMed ID: 35802302
[TBL] [Abstract][Full Text] [Related]
9. Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways.
Zhang Q; Kelly AP; Wang L; French SW; Tang X; Duong HS; Messadi DV; Le AD
J Invest Dermatol; 2006 Dec; 126(12):2607-13. PubMed ID: 16841034
[TBL] [Abstract][Full Text] [Related]
10. Silibinin Alleviates Lipopolysaccharide Induced Inflammation in Porcine Mammary Epithelial Cells via mTOR/NF-κB Signaling Pathway.
Xu S; Jiang X; Liu Y; Jiang X; Che L; Lin Y; Zhuo Y; Feng B; Fang Z; Hua L; Li J; Wang J; Ren Z; Sun M; Wu D
Mol Nutr Food Res; 2023 Jul; 67(14):e2200715. PubMed ID: 37183809
[TBL] [Abstract][Full Text] [Related]
11. UCHL1 aggravates skin fibrosis through an IGF-1-induced Akt/mTOR/HIF-1α pathway in keloid.
Guo C; Liang L; Zheng J; Xie Y; Qiu X; Tan G; Huang J; Wang L
FASEB J; 2023 Jul; 37(7):e23015. PubMed ID: 37256780
[TBL] [Abstract][Full Text] [Related]
12. Potent dual inhibitors of TORC1 and TORC2 complexes (KU-0063794 and KU-0068650) demonstrate in vitro and ex vivo anti-keloid scar activity.
Syed F; Sanganee HJ; Singh S; Bahl A; Bayat A
J Invest Dermatol; 2013 May; 133(5):1340-50. PubMed ID: 23303455
[TBL] [Abstract][Full Text] [Related]
13. Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma.
Ma Z; Liu W; Zeng J; Zhou J; Guo P; Xie H; Yang Z; Zheng L; Xu S; Wang X; Chang LS; He D; Li L
Oncol Rep; 2015 Nov; 34(5):2461-8. PubMed ID: 26323996
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
15. Effect of dual mTOR inhibitor on TGFβ1-induced fibrosis in primary human urethral scar fibroblasts.
Huang S; Yang C; Li M; Wang B; Chen H; Fu D; Chong T
Biomed Pharmacother; 2018 Oct; 106():1182-1187. PubMed ID: 30119186
[TBL] [Abstract][Full Text] [Related]
16. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
17. Hexose sugars differentially alter collagen gene expression and synthesis in fibroblasts derived from granulation tissue, hypertrophic scar and keloid.
Kössi J; Vähä-Kreula M; Peltonen J; Risteli J; Laato M
Arch Dermatol Res; 2004 May; 295(12):521-6. PubMed ID: 15045512
[TBL] [Abstract][Full Text] [Related]
18. Wubeizi Ointment Suppresses Keloid Formation through Modulation of the mTOR Pathway.
Tang Z; Cao Y; Ding J; Zhai X; Jing M; Wang M; Lu L
Biomed Res Int; 2020; 2020():3608372. PubMed ID: 33062677
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Do DV; Ong CT; Khoo YT; Carbone A; Lim CP; Wang S; Mukhopadhyay A; Cao X; Cho DH; Wei XQ; Bellone G; Lim I; Phan TT
Br J Dermatol; 2012 Jun; 166(6):1275-88. PubMed ID: 22050194
[TBL] [Abstract][Full Text] [Related]
20. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids.
Lee WJ; Ahn HM; Roh H; Na Y; Choi IK; Lee JH; Kim YO; Lew DH; Yun CO
Exp Dermatol; 2015 Aug; 24(8):591-7. PubMed ID: 25865370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
